Commit To Purchase OncoMed Pharmaceuticals At $12.50, Earn 23% Annualized Using Options
April 28, 2016 at 11:41 AM EDT
Investors eyeing a purchase of OncoMed Pharmaceuticals Inc. (OMED) shares, but cautious about paying the going market price of $14.89/share, might benefit from considering selling puts among the alternative strategies at their disposal..